BeOne Medicines Ltd. Financial Ratios — ONC Stock

Profitability (USD)

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-55.88	-67.03	-45.63	-12.82	-40.88	-49.13	-45.06	-20.63	-26.87	-14.47	-11	4.07
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-4.43
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6.14
Gross Margin (%)	-20.77	-67.72	100	100	97.91	85.52	83.38	77.12	85.98	79.77	84.55	84.41	87.49
EBITDA Margin (%)	-34.68	-108.94	-626.13	-10,761.78	-39.31	-350.81	-219.81	-526.39	-118.36	-121.71	-45.55	-10.4	11.02
Operating Margin (%)	-48.96	-120.88	-643.66	-10,940.19	-41.3	-356.05	-224.16	-536.69	-122.31	-126.4	-49.12	-14.91	8.37
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	66.24
Pretax Margin (%)	-70.81	-142.28	-647.71	-11,136.73	-38.2	-348.01	-220.35	-523.9	-122.3	-138.5	-33.59	-13.99	7.8
Profit Margin (%)	-67.22	-140.22	-647.71	-11,141.78	-39.06	-339.91	-221.53	-526.1	-123.93	-141.52	-35.86	-16.92	5.37
Net Income to Common Margin (%)	-67.22	-140.22	-647.71	-11,141.78	-39.06	-339.91	-221.53	-526.1	-123.93	-141.52	-35.86	-16.92	5.37
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	31.17
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	27	14	21	17	165	198	277	562	695	597	930	1,080	1,093
ST Debt	12	- -	15	- -	9	9	11	349	449	353	710	869	78
LT Debt	15	14	6	17	155	190	267	213	245	244	220	211	1,015
Total Debt/EBITDA	-7.08	-0.97	-0.38	-0.15	-1.76	-0.29	-0.29	-0.35	-0.5	-0.35	-0.83	-2.72	1.86
Net Debt/EBITDA	-6.06	- -	-0.05	0.61	0.8	0.74	0.4	0.53	2.69	1.93	2.04	4.06	-5.99
Total Debt/EBIT	-5.01	-0.88	-0.37	-0.15	-1.67	-0.28	-0.29	-0.34	-0.48	-0.33	-0.77	-1.9	2.44
Net Debt/EBIT	-4.29	- -	-0.05	0.6	0.76	0.73	0.39	0.52	2.6	1.86	1.89	2.83	-7.89
EBITDA to Interest Expense	-1.23	-4	-44.91	- -	- -	- -	- -	- -	- -	- -	-256.66	-18.18	10.11
EBITDA-CapEx/Interest Expense	-1.31	-4.18	-49.24	- -	- -	- -	- -	- -	- -	- -	-393.29	-42.45	5.53
EBIT to Interest Expense	-1.73	-4.44	-46.17	- -	- -	- -	- -	- -	- -	- -	-276.75	-26.06	7.68
Interest Expense	3	4	1	- -	- -	- -	- -	- -	- -	- -	4	22	58
Common Equity/Total Assets	-362.82	-113.91	-101.22	-58.49	-31.58	-44.77	-121.3	-63.43	-59.47	-110.99	-137.15	-145.36	-101.6
Long-Term Debt/Equity (%)	- -	52.45	8.33	4.9	22.73	10.82	27.24	5.51	4	5.56	6.22	6.32	23.27
Long-Term Debt/Capital (%)	-111.43	42.82	7.86	-7.85	-102.76	-23.88	-16.03	-7.12	-5.59	-3.76	-3.13	-2.8	-14.04
Long-Term Debt/Total Assets (%)	129.16	25.21	5.3	4.26	14.86	8.43	16.53	3.8	2.87	3.82	3.79	3.56	12.39
Total Debt/Equity (%)	-70.66	53.7	27.97	4.9	24.07	11.31	28.35	14.52	11.33	13.61	26.3	32.41	25.06
Total Debt/Capital (%)	-200.1	43.84	26.42	-7.85	-108.85	-24.98	-16.68	-18.79	-15.85	-9.2	-13.23	-14.35	-15.12
Total Debt/Total Assets (%)	231.94	25.81	17.8	4.26	15.74	8.82	17.2	10.03	8.14	9.35	16.02	18.24	13.35
Net Debt to Equity	-60.52	-0.23	3.92	-19.9	-10.94	-29.34	-38.57	-22.31	-61.08	-76	-64.62	-48.3	-80.9
Net Debt/Capital (%)	-133.16	-0.34	4.8	22.83	19.16	34.14	16.55	19.74	42.78	32.18	22.4	15.85	29.97
EBITDA	-4	-14	-55	-115	-94	-695	-941	-1,626	-1,392	-1,723	-1,120	-396	589
EBITDA-CapEx	-4	-15	-61	-139	-152	-836	-1,100	-1,853	-1,707	-2,192	-1,716	-926	322
Operating Income (Loss)	-5	-16	-57	-117	-98	-706	-960	-1,658	-1,439	-1,790	-1,208	-568	447

Liquidity (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	0.12	3.32	2.86	10.5	5.58	7.23	3.17	4.33	4.14	3.09	1.75	1.19	2.49
Current Ratio	0.14	3.53	3.02	10.68	6.09	7.89	3.78	4.61	4.76	3.55	2.32	1.8	3.41
Quick Ratio	0.12	3.32	2.86	10.5	5.79	7.44	3.42	4.4	4.45	3.22	1.97	1.51	2.97
CFO/Avg Current Liab	- -	-0.39	-1.64	-2.55	0.14	-2.76	-2.7	-1.85	-0.97	-0.98	-0.71	-0.07	0.56
Common Equity/Total Assets	-362.82	-113.91	-101.22	-58.49	-31.58	-44.77	-121.3	-63.43	-59.47	-110.99	-137.15	-145.36	-101.6
Long-Term Debt/Equity (%)	- -	52.45	8.33	4.9	22.73	10.82	27.24	5.51	4	5.56	6.22	6.32	23.27
Long-Term Debt/Capital (%)	-111.43	42.82	7.86	-7.85	-102.76	-23.88	-16.03	-7.12	-5.59	-3.76	-3.13	-2.8	-14.04
Long-Term Debt/Total Assets (%)	129.16	25.21	5.3	4.26	14.86	8.43	16.53	3.8	2.87	3.82	3.79	3.56	12.39
Total Debt/Equity (%)	-70.66	53.7	27.97	4.9	24.07	11.31	28.35	14.52	11.33	13.61	26.3	32.41	25.06
Total Debt/Capital (%)	-200.1	43.84	26.42	-7.85	-108.85	-24.98	-16.68	-18.79	-15.85	-9.2	-13.23	-14.35	-15.12
Total Debt/Total Assets (%)	231.94	25.81	17.8	4.26	15.74	8.82	17.2	10.03	8.14	9.35	16.02	18.24	13.35
CFO/Total Liabilities	8.06	-31.21	-93.87	-169.19	3.52	-110.42	-118.35	-74.12	-54.05	-74.98	-51.04	-5.43	29.46
CFO/CapEx	15.43	-13.29	-7.5	-3.81	0.22	-3.89	-4.73	-5.65	-4.12	-3.19	-1.94	-0.27	4.23
Altman's Z-Score	3.13	-1.36	24.49	12.9	7.73	8.72	6.57	6.49	5.87	5.24	3.26	3.13	5.25

Working Capital (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	16.2	5.62	7.65	4.71	4.33	4.31	9.26	7.37	6.93
Days Sales Outstanding	- -	- -	- -	- -	22.53	64.89	47.71	77.57	84.33	84.59	39.43	49.54	52.65
Inventory Turnover	- -	- -	- -	- -	0.91	2.11	3.18	1.2	0.99	1.09	1.09	1.3	1.21
Days Inventory Outstanding	- -	- -	- -	- -	401.03	172.75	114.83	304.38	367.33	334.44	335.52	279.89	301.16
Accounts Payable Turnover	- -	9	- -	- -	0.39	0.37	0.71	0.74	1.29	1.17	1.68	1.87	1.77
Accounts Payable Turnover Days	- -	40.55	- -	- -	937.93	982.12	515.3	492.3	283.5	311.73	216.68	195.29	206.37
Cash Conversion Cycle	- -	-40.55	- -	- -	-514.37	-744.47	-352.76	-110.34	168.16	107.29	158.27	134.14	147.44
Inventory to Cash Days	- -	- -	- -	- -	-378.5	-107.86	-67.13	-226.82	-283.01	-249.85	-296.09	-230.35	-248.51
Inventories	- -	- -	- -	- -	11	16	29	89	243	282	416	495	608
Raw Materials	- -	- -	- -	- -	- -	- -	- -	19	78	89	149	171	236
Work In Process	- -	- -	- -	- -	- -	- -	- -	1	9	21	39	60	123
Finished Goods	- -	- -	- -	- -	11	16	29	69	155	173	228	264	249
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	974	9	1,889	1,205	4,451	7,776	9,955	21,568	25,138	22,683	18,827	19,448	33,134
- Cash & Cash Equivalents	4	14	18	88	240	713	618	1,382	4,376	3,870	3,172	2,627	4,548
+ Preferred Equity and Hybrid Capital	- -	79	176	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	2	- -	- -	- -	14	14	16	- -	- -	- -	- -	- -	- -
+ Total Debt	27	14	21	17	165	198	277	562	695	597	930	1,080	1,093
Enterprise Value	999	58	1,986	854	3,792	6,208	9,265	17,480	19,215	18,745	16,583	17,900	29,679
Total Capital	-14	32	79	-220	-151	-794	-1,662	-2,991	-4,382	-6,484	-7,032	-7,527	-7,227
Total Debt/Capital (%)	-200.1	43.84	26.42	-7.85	-108.85	-24.98	-16.68	-18.79	-15.85	-9.2	-13.23	-14.35	-15.12
Total Debt / EV	0.03	0.24	0.01	0.02	0.04	0.03	0.03	0.03	0.04	0.03	0.06	0.06	0.04
EV/Sales	89.65	4.43	225.25	797.93	15.91	31.32	21.64	56.59	16.34	13.24	6.74	4.7	5.55
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	50.4
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	66.38
EV/Cash Flow to Firm	138.27	- -	- -	- -	297.38	- -	- -	- -	- -	- -	- -	- -	25.42
EV/Free Cash Flow to Firm	133.4	- -	- -	- -	53.05	- -	- -	- -	- -	- -	- -	43.15	20.69
Diluted Market Cap	974	9	1,889	1,205	4,451	7,776	9,955	21,568	25,138	22,683	18,827	19,448	34,467
Diluted Enterprise Value	999	88	2,068	1,134	4,390	7,276	9,630	20,748	21,457	19,410	16,586	17,900	31,012
EV per Share	18.98	1.1	63.01	21.52	83.26	111.97	154.28	209.41	207.09	181.75	158.86	170.01	272.13
TTM Sales	11	13	9	1	238	198	428	309	1,176	1,416	2,459	3,810	5,343
TTM EBITDA	-4	-14	-55	-115	-94	-695	-941	-1,626	-1,392	-1,723	-1,120	-396	589
TTM Operating Income	-5	-16	-57	-117	-98	-706	-960	-1,658	-1,439	-1,790	-1,208	-568	447
TTM Cash Flow to Firm	7	-5	-39	-90	13	-548	-750	-1,283	-1,299	-1,497	-1,153	-114	1,168
TTM Free Cash Flow to Firm	7	-4	-33	-66	71	-407	-592	-1,056	-984	-1,028	-557	415	1,434

Multiples (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	224.63	-1.18	-54.72	-18.25	62.26	-19.11	-16.82	-20.42	-25.55	-22.08	-33.55	50.06	24.72
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	66.38
Enterprise Value	999	58	1,986	854	3,792	6,208	9,265	17,480	19,215	18,745	16,583	17,900	29,679
Low Price	11.06	0.17	0.17	22.51	29.58	95.34	108	118.55	222.21	118.18	156.56	126.97	172.67
EV/Sales	89.65	4.43	225.25	797.93	15.91	31.32	21.64	56.59	16.34	13.24	6.74	4.7	5.55
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	50.4
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	115.48
Price/Earnings Average	-127.55	-91.97	-19.17	-10.8	-29.63	-12.66	-8.88	-10.68	-21.11	-9.31	-25.1	-28.59	105.84
Price/Earnings High	-133.44	-201.65	-35.27	-24.6	-58.19	-18.11	-13.32	-16.59	-27.15	-14.19	-33.22	-40.52	146.42
Price/Earnings Low	-77.72	-0.48	-0.09	-7.49	-14.47	-7.85	-6.84	-6.09	-14.14	-6.08	-18.54	-20.73	65.63
Price/Book Value	-22.76	-0.16	-15.99	-5.08	-13.47	-7.72	-5.09	-6.07	-4.95	-3.2	-2.36	-2.26	-3.98
Price/Book Value Average	-22.33	-27.52	-9.26	-5.43	-8.35	-8.47	-4.31	-4.89	-6.06	-2.64	-2.78	-2.14	-3.65
Price/Book Value High	-23.36	-60.34	-17.04	-12.35	-16.39	-12.12	-6.46	-7.59	-7.8	-4.02	-3.68	-3.04	-5.05
Price/Book Value Low	-13.61	-0.14	-0.04	-3.76	-4.08	-5.25	-3.32	-2.79	-4.06	-1.72	-2.05	-1.55	-2.26
Price/Tangible Book Value	-25.16	-0.18	-18.57	3.41	6.7	4.57	10.76	5.65	4.17	5.29	5.49	6.07	7.85
Price/Tangible Book Value Average	-24.68	-31.69	-10.75	3.65	4.15	5.01	9.11	4.55	5.11	4.35	6.46	5.76	7.2
Price/Tangible Book Value High	-25.82	-69.49	-19.79	8.31	8.15	7.17	13.65	7.07	6.56	6.63	8.54	8.16	9.96
Price/Tangible Book Value Low	-15.04	-0.17	-0.05	2.53	2.03	3.11	7.01	2.59	3.42	2.84	4.77	4.17	4.46
Price/Sales	87.39	0.73	214.32	1,125.86	18.67	39.23	23.25	69.83	21.37	16.02	7.66	5.1	6.2
Price/Sales Average	85.74	128.97	124.15	1,203.47	11.57	43.04	19.68	56.2	26.17	13.18	9	4.84	5.68
Price/Sales High	89.7	282.75	228.44	2,740.48	22.73	61.56	29.5	87.28	33.65	20.08	11.91	6.86	7.86
Price/Sales Low	52.24	0.68	0.6	834.75	5.65	26.67	15.15	32.04	17.53	8.61	6.65	3.51	3.52
Price/Cash Flow	239.19	-1.09	-47.42	-13.46	349.01	-14.2	-13.27	-16.8	-19.36	-15.16	-16.27	-138.29	29.39
Price/Cash Flow Average	234.69	-193.36	-27.47	-14.39	216.33	-15.58	-11.23	-13.52	-23.7	-12.47	-19.12	-131.09	26.93
Price/Cash Flow High	245.52	-423.94	-50.55	-32.76	424.83	-22.28	-16.84	-21.01	-30.47	-19	-25.31	-185.79	37.26
Price/Cash Flow Low	143	-1.02	-0.13	-9.98	105.65	-9.65	-8.64	-7.71	-15.88	-8.14	-14.12	-95.06	16.7
Price/Free Cash Flow Average	220.4	-209.09	-31.7	-19.51	38.59	-20.97	-14.24	-16.43	-31.29	-18.16	-39.44	47.45	22.66
Price/Free Cash Flow High	230.58	-458.42	-58.33	-44.42	75.79	-29.99	-21.35	-25.52	-40.23	-27.67	-52.2	67.25	31.35
Price/Free Cash Flow Low	134.29	-1.1	-0.15	-13.53	18.85	-12.99	-10.96	-9.37	-20.96	-11.86	-29.12	34.41	14.05
EV/Sales Average	88.01	135.01	144.45	1,137.83	11.32	40.52	18.92	53.54	23.04	10.87	8.09	4.43	5.04
EV/Sales High	91.97	288.8	248.75	2,674.85	22.47	59.04	28.74	84.63	30.52	17.77	11	6.45	7.22
EV/Sales Low	54.51	6.72	20.9	769.12	5.4	24.14	14.39	29.38	14.4	6.3	5.74	3.1	2.88
EV/EBITDA Average	-253.77	-123.93	-23.07	-10.57	-28.8	-11.55	-8.61	-10.17	-19.46	-8.93	-17.76	-42.6	45.71
EV/EBITDA High	-265.19	-265.1	-39.73	-24.86	-57.17	-16.83	-13.08	-16.08	-25.78	-14.6	-24.15	-62	65.48
EV/EBITDA Low	-157.17	-6.17	-3.34	-7.15	-13.73	-6.88	-6.55	-5.58	-12.16	-5.17	-12.59	-29.82	26.11
EV/EBIT Average	-179.75	-111.69	-22.44	-10.4	-27.4	-11.38	-8.44	-9.98	-18.84	-8.6	-16.47	-29.72	60.19
EV/EBIT High	-187.84	-238.91	-38.65	-24.45	-54.41	-16.58	-12.82	-15.77	-24.95	-14.06	-22.4	-43.26	86.23
EV/EBIT Low	-111.33	-5.56	-3.25	-7.03	-13.07	-6.78	-6.42	-5.47	-11.77	-4.98	-11.68	-20.8	34.39
Last Price	18.5	0.18	59.95	30.36	97.72	140.26	165.76	258.39	270.93	219.94	180.36	184.71	303.81
High Price	18.99	69.99	63.9	73.9	118.95	220.1	210.35	322.98	426.56	275.72	280.62	248.16	385.22
Enterprise Value Average	981	1,760	1,273	1,217	2,698	8,032	8,102	16,539	27,100	15,386	19,894	16,887	26,915
Enterprise Value High	1,025	3,764	2,193	2,862	5,357	11,703	12,308	26,140	35,898	25,163	27,052	24,581	38,558
Enterprise Value Low	608	88	184	823	1,287	4,786	6,161	9,076	16,937	8,915	14,101	11,821	15,377

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	410	410	410	516	592	775	801	1,191	1,335	1,356	1,355	1,385	1,441
Diluted Weighted Avg Shares	53	53	32	40	46	55	60	83	93	103	104	105	113
Basic Weighted Avg Shares	53	53	32	40	46	55	60	83	93	103	104	105	109
Revenue per Share	0.21	0.25	0.28	0.03	5.23	3.58	7.13	3.7	12.68	13.73	23.55	36.19	48.99
EBITDA per Share	-0.07	-0.27	-1.75	-2.9	-2.06	-12.54	-15.67	-19.48	-15.01	-16.71	-10.73	-3.77	5.4
Operating Income per Share	-0.1	-0.3	-1.8	-2.95	-2.16	-12.73	-15.98	-19.86	-15.51	-17.35	-11.57	-5.4	4.1
Basic EPS, GAAP	-0.14	-0.35	-1.81	-3	-2.04	-12.15	-15.8	-19.47	-15.71	-19.43	-8.45	-6.12	2.63
Basic EPS from Cont Ops	-0.15	-0.35	-1.81	-3	-2.05	-12.16	-15.83	-19.51	-15.71	-19.43	-8.45	-6.12	2.63
Diluted EPS, GAAP	-0.14	-0.35	-1.81	-3	-2.04	-12.15	-15.8	-19.47	-15.71	-19.43	-8.45	-6.12	2.53
Diluted EPS from Cont Ops	-0.15	-0.35	-1.81	-3	-2.05	-12.16	-15.83	-19.51	-15.71	-19.43	-8.45	-6.12	2.53
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	0.08	-0.17	-1.26	-2.26	0.28	-9.88	-12.49	-15.38	-14	-14.51	-11.09	-1.34	10.34
Free Cash Flow per Basic Share	0.07	-0.18	-1.43	-2.85	-1.01	-12.42	-15.13	-18.1	-17.39	-19.06	-16.8	-6.36	7.9
Cash & Equivalents per Share	0.07	0.84	3.19	9.28	18.39	32.13	16.36	55.72	71.32	43.97	30.41	24.95	41.7
Book Value per Share	-0.81	-1.16	-3.75	-5.98	-7.26	-18.17	-32.57	-42.56	-54.71	-68.65	-76.27	-81.74	-76.28
Tangible Book Value per Share	-0.74	-1.01	-3.23	8.89	14.59	30.69	15.41	45.71	64.98	41.58	32.84	30.42	38.69

BeOne Medicines Ltd.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)